PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,358 stories, page 180 of 623

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

White House to Announce New Drug Pricing Deals With Biotechs

Bloomberg.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biophytis (BPTSY) leans on Asia JV to fund BIO101 Phase 3 push

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Key FDA Updates: Substantial Evidence, Gene Therapy Development and AI-Enabled Early-Phase Clinical Trials

McGuireWoodsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease

Scientific AmericanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves landmark pancreatic cancer drug that's shown to improve survival

The Tribune-DemocratOriginal source
🇺🇰Researchguysandstthomas.nhs.ukTier 2 · Direct publisher

Tackling local health inequalities

St Thomas' Hospital LondonOriginal source
🇯🇵Industrynippon-shinyaku.co.jpTier 1 · Company source

福山型先天性筋ジストロフィー治療剤「NS-035」先駆的医薬品指定のお知らせ

Nippon Shinyaku NewsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

FDA greenlights RevMed’s pancreatic cancer gamechanger

Fierce PharmaOriginal source
🇺🇸CROadvarra.comTier 2 · Direct publisher

SIV Training Is Still Too Redundant. The Data Shows Where to Start.

Advarra (IRB)Original source
🌍Regulatoryifpma.orgTier 1 · Regulatory source

76th WHO Regional Committee for Africa: Special update on the ongoing Ebola virus disease outbreak caused by Bundibugyo Virus

IFPMA GlobalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe Says ‘I Am No Celebrity’, Dismisses ‘Internet Fame’ Amid Food Safety Crackdown

LatestLYOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 35 report: data to week 34 (data up to 23 August 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate

Fierce PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks Facing FDA Decision In September 2026

RTTNewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Can Predictive Modelling Fix Fragmented Pharma Development Data?

PharmTech.comOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Understanding and managing infection in adult social care

Information resources to support understanding of health protection hazards in adult social care set...

UK Health Security AgencyOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Sustainable 4D hydrogels functionalised with plant-based nanoparticles for bone regeneration in cancer patients

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Environmental Effect on Health Care and Wellbeing and Active Interventions

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Deciphering Alzheimer’s disease molecular subtypes to advance treatment development.

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Integrated multi-angle research and training network to eradicate leukemia minimal residual disease

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth

PR NewswireOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Next generation ketoamide inhibitors of fibroblast activation protein (FAP) to revolutionize radionuclide therapy in cancer.

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA putting mechanism in place to ensure food safety during festive season: Tukaram Mundhe

Moneycontrol.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Libya Ministry of Health Expands PharmaGate Digital Registration Syste

Libya HeraldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cracks down on mid-day meal, tightens blood bank rules | Check details

India.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe: 'My Vested Interest Is...'

RediffOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Key data on a new class of cardio drugs are coming

STATOriginal source
🇿🇦Regulatorysahpra.org.zaTier 1 · Regulatory source

South Africa Maintains WHO Maturity Level 3 (ML3) for Vaccine Regulation

SAHPRA South AfricaOriginal source
🌍Researchanswers.childrenshospital.orgTier 2 · Direct publisher

New approach to gene therapy helps smooth road for people with sickle cell disease

Boston Children's HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Summit Therapeutics Inc Stock (SMMT) Moved Up by 8.95% on Aug 26: Drivers Behind the Movement

TradingKeyOriginal source
🌍Regulatoryifpma.orgTier 1 · Regulatory source

76th WHO Regional Committee for Africa: Regional strategy on regulation of medical products in the African region, 2026-2035

IFPMA GlobalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting

The Motley FoolOriginal source
🌍Regulatoryifpma.orgTier 1 · Regulatory source

AMATA Statement at WHO Regional Committee for Africa: Regional strategy on regulation of medical products in the African Region, 2026-2035

IFPMA GlobalOriginal source
🇯🇵Industrynippon-shinyaku.co.jpTier 1 · Company source

低分子化合物 分析・分取プラットフォームの導入

Nippon Shinyaku NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AMA calls for stronger regulatory systems to support Africa’s pharmaceutical manufacturing

Tech Review AfricaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Centrix and University of Sussex Collaborate to Drive Data-Driven Pharma Development

Genetic Engineering and Biotechnology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Grand Pharmaceutical H1 revenue rises on nuclear medicine demand

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

AI biotech Insitro’s Daphne Koller on how to speed up clinical trials

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Grand Pharmaceutical Group: Revenue up 3.2% to HK$6.39B, with strong nuclear medicine growth and robust R&D pipeline

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

JATT mastermind launches latest biotech-focused SPAC in $60M IPO

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Authorizes First Ketone, Blood Sugar Monitor for Diabetes

Drug TopicsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Safety Groups Sound Alarm After FDA Compounding Panel Backs 6 of 7 Peptides

Specialty Pharmacy ContinuumOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

5 Biotech Stocks Worth Adding to Your Portfolio Now

Zacks Investment ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA putting mechanism in place to ensure food safety during festive season, says Tukaram Mundhe

Telegraph IndiaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pharmalittle: We're reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and more

STATOriginal source
🇺🇸Devicesbtig.comTier 1 · Company source

U.S. Bancorp | BTIG Appoints Mangesh Ghogre as Managing Director, Metals & Mining Coverage

BTIGOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

No Exemption For 5-Star Eateries In Food Safety Crackdown: FDA Chief Tukaram Mundhe At Mumbai Press Club

Free Press JournalOriginal source
🌍Industryeikontx.comTier 1 · Company source

Eikon Therapeutics to Participate in Investor Conferences in September 2026

Eikon TherapeuticsOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Giardia cases in England reach highest level since 2016

Cases up 11.4% in 2025, with London recording the highest number of cases.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Shenzhen YHLO Biotech : Net profit surged 166.97% YoY on 9.84% revenue growth and improved margins

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lundbeck expands Eversana tie-up to scale AI across USA

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA plans two new deputy commissioner roles for tech and drugs

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sword Health set to buy Headspace parent OrangeDot

The Pharma LetterOriginal source
🌍Industryfarmak.uaTier 1 · Company source

The Bell of Kyiv’s Church of the Tithes Rings Again After Nearly 800 Years

Farmak (Ukraine)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Hong Kong customs seizes HK$11m of suspected sex pills, cancer drugs at warehouse

South China Morning PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Haisco licenses drug to US venture for $1.5bn

BioXconomyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viva Biotech Holdings Reports Earnings Results for the Half Year Ended June 30, 2026

marketscreener.comOriginal source